1. Lessons of microbiota
    Z.D. Semidotskaya et al, 2019, Shidnoevr. z. vnutr. simejnoi med. CrossRef
  2. The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
    Zuzanna Urban-Wojciuk et al, 2019, Front. Immunol. CrossRef
  3. Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment
    Sara Saab et al, 2020, Front. Immunol. CrossRef
  4. Targets for protection and mitigation of radiation injury
    Ehsan khodamoradi et al, 2020, Cell. Mol. Life Sci. CrossRef
  5. The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
    Shuai Wang et al, 2020, Front. Immunol. CrossRef
  6. Out-Smarting the Host: Bacteria Maneuvering the Immune Response to Favor Their Survival
    Nastaran Mues et al, 2020, Front. Immunol. CrossRef
  7. null
    Mahmud Angrini et al, 2020 CrossRef
  8. Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
    Asunción Espinosa-Sánchez et al, 2020, Front. Oncol. CrossRef
  9. Immunopathogenicity of Acanthamoeba spp. in the Brain and Lungs
    Karolina Kot et al, 2021, IJMS CrossRef
  10. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
    Valentino Le Noci et al, 2021, Front. Cell Dev. Biol. CrossRef
  11. Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
    Fernando Torres Andón et al, 2022, Biomedicines CrossRef
  12. TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
    Jurica Baranašić et al, 2022, Biomedicines CrossRef
  13. Toll-like receptors 2, 4, and 9 modulate promoting effect of COPD-like airway inflammation on K-ras-driven lung cancer through activation of the MyD88/NF-ĸB pathway in the airway epithelium
    Walter V. Velasco et al, 2023, Front. Immunol. CrossRef
  14. THE EXPRESSION OF TLR4, IFN-γ, TGF-β AND TNF-αLL LINE OF HUMAN SMALL CELL LUNG CARCINOMA NCI-H69 AND IN CISPLATIN-RESISTANT SUBLINE NCI-H69/CPR
    I. Stupak, 2022, Biotechnol. acta CrossRef
  15. null
    Nadiia Kasianchuk et al, 2023 CrossRef